ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.
NCT03792568 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2019-02-15
Summary
This clinical trial aims to evaluate the efficacy, safety of ALK inhibitor in Metastatic Colorectal Cancer Patients with ALK mutation.
Conditions
Interventions
- OTHER
-
ALK Inhibitor
Any ALK inhibitor like crizotinib, alectinib and so on.
Sponsors & Collaborators
-
Shanghai Changzheng Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2019-03-01
- Completion
- 2021-03-01
Countries
- China
Study Locations
More Related Trials
-
Preserving Left Colonic Artery During Radical Resection of Rectal Cancer
NCT03776370 ·Status: COMPLETED
-
Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer Enterostomy
NCT07172087 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
NCT07050394 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NCT06449937 ·Status: RECRUITING ·Phase: NA
-
Strengthening the Spleen and Reducing Phlegm Method in Improving Radical Resection Rate of Colorectal Cancer
NCT03716063 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer
NCT04499586 ·Status: UNKNOWN ·Phase: PHASE2
-
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
NCT04714814 ·Status: UNKNOWN
-
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
NCT06621173 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases
NCT01677728 ·Status: UNKNOWN
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03679039 ·Status: UNKNOWN
-
Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer
NCT03359616 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13）
NCT05794750 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases
NCT01959061 ·Status: UNKNOWN ·Phase: PHASE4
-
CRC Post-surgical Assessment and Recurrence Monitoring
NCT03334890 ·Status: UNKNOWN
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN
-
Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC
NCT02893540 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
NCT06858956 ·Status: NOT_YET_RECRUITING
-
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
NCT05871762 ·Status: RECRUITING
-
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 ·Status: RECRUITING
-
Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer
NCT05676190 ·Status: RECRUITING ·Phase: NA
-
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
NCT06120127 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer
NCT05414461 ·Status: COMPLETED ·Phase: PHASE2
-
Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients
NCT03030508 ·Status: UNKNOWN